Nalu Bio

Nalu Bio is unlocking the full potential of the endocannabinoid system (ECS)—the body’s natural balancing system—to transform the future of health and wellness. Our proprietary ECS Technology Platform uses AI and biological modeling to accelerate the development of prescription therapeutics and nonprescription wellness products. In just two weeks, our platform can generate and prioritize novel, biologically relevant drug candidates. Our drug discovery process is 5X faster than industry standards. By targeting the ECS, we’re addressing today’s biological mismatch: chronic inflammation, metabolic dysfunction, and immune dysregulation driven by stress, sedentary lifestyles, and processed diets. Our ECS pipeline is focused on multi-billion-dollar markets in inflammatory, immune, and metabolic diseases: ECS Therapeutics – precision-engineered compounds designed to match or exceed the efficacy of opioids and NSAIDs—without the side effects or risk of addiction. Our lead program is first-in-class for pain, inflammation, and endometriosis. meld Wellness – AI-generated cannabinoid + vitamin blends formulated specifically for women’s health. Each product is ECS-optimized, backed by science, and built to deliver consistent, safe, no-high support for stress, sleep, and mobility. Nalu Bio was founded by a team of biotech leaders and scientists dedicated to making ECS-based health solutions reliable, scalable, and trusted. Our mission is to solve modern health challenges with smarter molecules—and bring the ECS into the medical mainstream. Learn more at nalubio.com or get in touch at hello@nalubio.com